117 related articles for article (PubMed ID: 3361571)
21. Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.
Vernall AJ; Stoddart LA; Briddon SJ; Hill SJ; Kellam B
J Med Chem; 2012 Feb; 55(4):1771-82. PubMed ID: 22277057
[TBL] [Abstract][Full Text] [Related]
22. 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Tralli A; Montopoli C; Moro S
Bioorg Med Chem; 2005 Feb; 13(3):705-15. PubMed ID: 15653338
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Bioorg Med Chem; 2003 Dec; 11(24):5509-18. PubMed ID: 14642595
[TBL] [Abstract][Full Text] [Related]
24. C2,N6-disubstituted adenosines: synthesis and structure-activity relationships.
Trivedi BK; Bruns RF
J Med Chem; 1989 Aug; 32(8):1667-73. PubMed ID: 2754691
[TBL] [Abstract][Full Text] [Related]
25. [1,2,4]Triazolo[1,5-c]pyrimidines as adenosine receptor antagonists: Modifications at the 8 position to reach selectivity towards A
Federico S; Margiotta E; Salmaso V; Pastorin G; Kachler S; Klotz KN; Moro S; Spalluto G
Eur J Med Chem; 2018 Sep; 157():837-851. PubMed ID: 30144700
[TBL] [Abstract][Full Text] [Related]
26. 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors.
Linden J; Patel A; Earl CQ; Craig RH; Daluge SM
J Med Chem; 1988 Apr; 31(4):745-51. PubMed ID: 3351850
[TBL] [Abstract][Full Text] [Related]
27. 1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.
van Galen PJ; Nissen P; van Wijngaarden I; IJzerman AP; Soudijn W
J Med Chem; 1991 Mar; 34(3):1202-6. PubMed ID: 2002461
[TBL] [Abstract][Full Text] [Related]
28. 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
Catarzi D; Colotta V; Varano F; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Montopoli C; Moro S
J Med Chem; 2005 Dec; 48(25):7932-45. PubMed ID: 16335918
[TBL] [Abstract][Full Text] [Related]
29. Nucleosides and nucleotides. 103. 2-Alkynyladenosines: a novel class of selective adenosine A2 receptor agonists with potent antihypertensive effects.
Matsuda A; Shinozaki M; Yamaguchi T; Homma H; Nomoto R; Miyasaka T; Watanabe Y; Abiru T
J Med Chem; 1992 Jan; 35(2):241-52. PubMed ID: 1732541
[TBL] [Abstract][Full Text] [Related]
30. 4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Lenzi O; Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Varani K; Marighetti F; Morizzo E; Moro S
J Med Chem; 2006 Jun; 49(13):3916-25. PubMed ID: 16789747
[TBL] [Abstract][Full Text] [Related]
31. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
Shamim MT; Ukena D; Padgett WL; Daly JW
J Med Chem; 1989 Jun; 32(6):1231-7. PubMed ID: 2724296
[TBL] [Abstract][Full Text] [Related]
32. N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists.
Ukena D; Padgett WL; Hong O; Daly JW; Daly DT; Olsson RA
FEBS Lett; 1987 May; 215(2):203-8. PubMed ID: 3582647
[TBL] [Abstract][Full Text] [Related]
33. 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity.
Erickson RH; Hiner RN; Feeney SW; Blake PR; Rzeszotarski WJ; Hicks RP; Costello DG; Abreu ME
J Med Chem; 1991 Apr; 34(4):1431-5. PubMed ID: 2016719
[TBL] [Abstract][Full Text] [Related]
34. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors.
Daly JW; Padgett WL; Shamim MT
J Med Chem; 1986 Jul; 29(7):1305-8. PubMed ID: 3806581
[TBL] [Abstract][Full Text] [Related]
35. Tricyclic heteroaromatic systems 1,2,4-triazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.
Catarzi D; Cecchi L; Colotta V; Melani F; Filacchioni G; Martini C; Giusti L; Lucacchini A
Farmaco; 1993 Aug; 48(8):1065-78. PubMed ID: 8216669
[TBL] [Abstract][Full Text] [Related]
36. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
37. Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-2H-1-one: potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET).
Holschbach MH; Bier D; Wutz W; Sihver W; Schüller M; Olsson RA
Eur J Med Chem; 2005 May; 40(5):421-37. PubMed ID: 15893016
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
Katsushima T; Nieves L; Wells JN
J Med Chem; 1990 Jul; 33(7):1906-10. PubMed ID: 1694546
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antibacterial activity of fused 1, 2, 4-triazolo[4, 3-a]quinoxaline and oxopyrimido[2', 1':5, 1]-1, 2, 4-triazolo[4, 3-a]quinoxaline derivatives.
Nasr MN
Arch Pharm (Weinheim); 2002 Aug; 335(8):389-94. PubMed ID: 12397623
[TBL] [Abstract][Full Text] [Related]
40. N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor.
Thompson RD; Secunda S; Daly JW; Olsson RA
J Med Chem; 1991 Sep; 34(9):2877-82. PubMed ID: 1895305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
